D-Dimer as Biomarker for Early Prediction of Clinical Outcomes in Patients With Severe Invasive Infections Due to Streptococcus Pneumoniae and Neisseria Meningitidis

Frontiers in Medicine

article

Simone Meini¹  Carolina Rescigno²  Luigi Atripaldi³  Silvia Leonardi³  Mariano Bernardo³  Carlo Tascini⁴  Emanuela Sozio⁴  Giacomo Bertolino⁵  Francesco Sbrana⁶  Andrea Ripoli⁶  Carlo Pallotto⁷  Bruno Viaggi⁹  Roberto Andreini¹  Vittorio Attanasio² 

[1] Internal Medicine Unit, Felice Lotti Hospital of Pontedera, Azienda Unità Sanitaria Locale Toscana Nord-Ovest;First Division of Infectious Diseases, Cotugno Hospital, Azienda Ospedaliera dei Colli;Central Laboratory, Azienda Ospedaliera dei Colli;Infectious Disease Unit, Department of Medicine, University of Udine;Pharmaceutical Department, Ospedale di Sassuolo;Fondazione Toscana Gabriele Monasterio;Infectious Diseases Unit 1, Santa Maria Annunziata Hospital, Azienda Unità Sanitaria Locale Toscana Centro;Section of Infectious Diseases, Department of Medicine, University of Perugia;Neuro Intensive Care Unit, Department of Anesthesiology, Careggi University Hospital

关键词: D-dimer;    biomarker;    sepsis;    meningitis;    Streptococcus pneumoniae;    Neisseria meningitidis;    mortality;   

DOI  :  10.3389/fmed.2021.627830

学科分类：社会科学、人文和艺术（综合）

来源: Frontiers

【 摘 要 】

Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection; no current clinical measure adequately reflects the concept of dysregulated response. Coagulation plays a pivotal role in the normal response to pathogens (immunothrombosis), thus the evolution toward sepsis-induced coagulopathy could be individuate through coagulation/fibrinolysis-related biomarkers. We focused on the role of D-dimer assessed within 24 h after admission in predicting clinical outcomes in a cohort of 270 patients hospitalized in a 79 months period for meningitis and/or bloodstream infections due to Streptococcus pneumoniae ( n = 162) or Neisseria meningitidis ( n = 108). Comparisons were performed with unpaired t -test, Mann-Whitney-test or chi-squared-test with continuity correction, as appropriate, and multivariable logistic regression analysis was performed with Bayesian model averaging. In-hospital mortality was 14.8% for the overall population, significantly higher in S. pneumoniae than in N. meningitidis patients: 19.1 vs. 8.3%, respectively ( p = 0.014). At univariable logistic regression analysis the following variables were significantly associated with in-hospital mortality: pneumococcal etiology, female sex, age, ICU admission, SOFA score, septic shock, MODS, and D-dimer levels. At multivariable analysis D-dimer showed an effect only in N. meningitidis subgroup: as 500 ng/mL of D-dimer increased, the probability of unfavorable outcome increased on average by 4%. Median D-dimer was significantly higher in N. meningitidis than in S. pneumoniae patients (1,314 vs. 1,055 ng/mL, p = 0.009). For N. meningitidis in-hospital mortality was 0% for D-dimer 7,000 ng/mL. Kaplan-Meier analysis of in-hospital mortality showed for N. meningitidis infections a statistically significant difference for D-dimer >7,000 ng/mL compared to values <500 ng/mL ( p = 0.021) and 500–3,000 ng/mL ( p = 0.002). For S. pneumoniae the mortality risk resulted always high, over 10%, irrespective by D-dimer values. In conclusion, D-dimer is rapid to be obtained, at low cost and available everywhere, and can help stratify the risk of in-hospital mortality and complications in patients with invasive infections due to N. meningitidis : D-dimer <500 ng/mL excludes any further complications, and a cut-off of 7,000 ng/mL seems able to predict a significantly increased mortality risk from much <10% to over 25%.

【 授权许可】

CC BY